Home/Investors/Peter Thiel

Peter Thiel

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$2.3B

Focus Areas

6

Top Stage

Phase 2

Investment Focus

Psychiatry Mental Health Neuroscience Oncology Immunology Infectious Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
atai Life Sciences	Phase 2	$1.3B	Psychiatry, Mental Health
AbCellera	Pre-clinical	$1.0B	Oncology, Immunology

Frequent Co-Investors

Thiel Capital1 shared Apeiron Investment Group1 shared Catalio Capital Management1 shared Woodline Partners1 shared OrbiMed1 shared DCVC1 shared Eli Lilly1 shared Viking Global Investors1 shared